Jatrorrhizine: A Review of Sources, Pharmacology, Pharmacokinetics and Toxicity

Bibliographic Details
Title: Jatrorrhizine: A Review of Sources, Pharmacology, Pharmacokinetics and Toxicity
Authors: Furong Zhong, Yang Chen, Jia Chen, Hailang Liao, Yirou Li, Yuntong Ma
Source: Frontiers in Pharmacology, Vol 12 (2022)
Publisher Information: Frontiers Media S.A., 2022.
Publication Year: 2022
Collection: LCC:Therapeutics. Pharmacology
Subject Terms: jatrorrhizine, natural products, pharmacological properties, toxicology, pharmacokinetics, Therapeutics. Pharmacology, RM1-950
More Details: Jatrorrhizine, an isoquinoline alkaloid, is a bioactive metabolite in common medicinal plants, such as Berberis vernae Schneid., Tinospora sagittata (Oliv.) Gagnep. and Coptis chinensis Franch. These plants have been used for centuries in traditional medicine for their wide-ranging pharmacological properties. This review emphasizes the latest and comprehensive information on the sources, pharmacology, pharmacokinetics and toxicity of jatrorrhizine. Studies on this alkaloid were collected from scientific internet databases, including the Web of Science, PubMed, ScienceDirect, Google Scholar, Elsevier, Springer, Wiley Online Library and Europe PMC and CNKI, using a combination of keywords involving “jatrorrhizine”, “sources”, “pharmacology,” “pharmacokinetics,” and “toxicology”. Jatrorrhizine exhibits anti-diabetic, antimicrobial, antiprotozoal, anticancer, anti-obesity and hypolipidemic properties, along with central nervous system activities and other beneficial activity. Studies of jatrorrhizine have laid the foundation for its application to the treatment of various diseases, but some issues still exist. Further investigations might emphasize 1) specific curative mechanisms of jatrorrhizine and clinical utility, 2) application prospect in the treatment of metabolic disorders, 3) comprehensive investigations of the toxicity mechanisms and 4) interactions of jatrorrhizine with other pharmaceuticals and development of derivatives.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1663-9812
Relation: https://www.frontiersin.org/articles/10.3389/fphar.2021.783127/full; https://doaj.org/toc/1663-9812
DOI: 10.3389/fphar.2021.783127
Access URL: https://doaj.org/article/cc2cfd44b3324457bb5e6bd380b0cd4b
Accession Number: edsdoj.2cfd44b3324457bb5e6bd380b0cd4b
Database: Directory of Open Access Journals
More Details
ISSN:16639812
DOI:10.3389/fphar.2021.783127
Published in:Frontiers in Pharmacology
Language:English